EIC Accelerator Report Card: RoBoTec's Laser Plant Cloning Robot

Almost every banana, orchid, berry bush and seed potato that starts life in a laboratory is cut by hand. A technician at a sterile bench takes a plantlet out of its jar, decides where to divide it, cuts it with a scalpel and places the pieces on fresh growth medium. RoBoTec PTC GmbH, a Bremen company founded in 2019 by Friederike and Stephan von Rundstedt, set out to hand that job to a machine. Its RoBoCut system photographs each plantlet in 3D, lets software choose the cutting lines, cuts with a laser and replants the pieces, all inside a sterile cell, as the CORDIS project summary describes it.

The European Commission selected the project in the 8 January 2020 cut-off of the EIC Accelerator pilot, grant only, with the company listed simply as "RBT" of Bremen in the official list of selected companies. No other beneficiary of the project appears there. CORDIS records an EU contribution of €2,473,747 towards a total cost of €3,533,925, with RoBoTec PTC GmbH as sole coordinator. The company itself rounds the grant to "2.4 million euros" on its press page and to "2.5 million euros" on its about page.

Where RoBoTec Stands Now

RoBoTec is active. Its share capital was raised twice after the EIC project, its annual accounts to 30 June 2025 were published on 4 March 2026, and a patent application on preparing materials for plant propagation was published in December 2025, according to the Bremen register entries collected by North Data. The company's imprint gives the same legal name, register number and Bremen address. In 2026 it is hiring a senior software engineer and describes RoBoCut as "not a lab prototype" but a machine that "already runs at customer sites internationally", on its careers page. In December 2025 Stephan von Rundstedt was a guest on the Horticulture Innovators podcast of the Texas A&M horticultural sciences department.

The figures inside those accounts are not freely available. North Data lists balance sheets for 2022 to 2025 but shows them only to paying subscribers, and no revenue, equity or headcount figure has been published by the company. How many systems RoBoTec has sold, and to whom, could not be verified.

The Technology: Laser Instead of Scalpel

Plant tissue culture multiplies plants clonally: a shoot grown on nutrient gel in a sealed vessel is divided again and again, each piece growing into a genetically identical copy. The method gives disease-free, uniform young plants, but each division needs a human judgement about where to cut. The CORDIS report puts this at about 30 decisions per minute per workplace; RoBoTec's 2026 press kit says 35, and claims that manual work makes up 60 to 70% of costs in European tissue culture. Much of that work, the CORDIS report says, has moved to low-wage countries.

RoBoCut replaces the scalpel with a CO₂ laser. In a March 2025 visit, top agrar described two robot arms moving plants from the growth medium into a laser box watched by three cameras each, software that picks the cutting points, and a laser that vaporises plant sap as it cuts, which the founders say limits cell damage and contamination. A scalpel tears tissue and can carry bacteria and fungi from one plant to the next, Friederike von Rundstedt told the magazine. The system runs on four industrial AI computers from Spectra, one controlling the machine and three training the models, according to a Spectra case study. The company now says more than 20 AI models work together in the machine and that all inference runs locally on the device.

The output figures differ by source. Stephan von Rundstedt told top agrar that the system singles out "a little more than 1,000 plants per hour" depending on the species. The company's product page now gives up to 2,500 plants an hour and up to 20 million a year per system at full load, and up to 85% lower costs than manual propagation. None of these numbers has been measured independently in public.

What the EIC Project Promised, and What CORDIS Shows

RoBoCut ran for 24 months, from 1 May 2020 to 30 April 2022, after a grant agreement signed on 21 April 2020. The objective on CORDIS set out to develop and market the system, introduce it first in Europe and America through a global distribution network, and reach "15% relevant market share and a turnover of 165 Mio Euros within the next years". Its long-term aim was "to equip all plant laboratories" with the machine.

The final periodic report, covering May 2021 to April 2022, is modest. It says the team refactored the software, optimised image processing and the AI component, and ran sterility tests over several weeks using positive air pressure, filters and UV light, with "excellent results". Pilot projects ran on the industrial prototype. A modularised production series was "currently being prepared". No deliverables, publications or sales were reported. The project ended on time, but at the prototype stage.

1. Reliable industrial prototype, sterile cellDeliveredSoftware rework and sterility tests reported on CORDIS; pilot projects on the prototype.
2. Series production of the machineLateOnly in preparation at project end; official launch announced in July 2024, with assembly by Hoyer, a Focke group company, per RoBoTec and top agrar.
3. Market entry in Europe and AmericaPartlySpectra says the first systems are being delivered and RoBoTec says they run at customer sites; no customer or US sale has been named.
4. 15% market share and €165M turnoverNot achievedNo revenue or market share has been announced by the company or anyone else.

The grant paid for a working machine, and that machine has since reached the market. The commercial promise in the proposal, a nine-figure turnover and a standard tool in every tissue culture laboratory, has no public evidence behind it four and a half years after the project closed.

What RoBoTec Has Achieved Since the Award

In December 2022 RoBoTec closed what it called a multi-million euro financing round, led by a family office from Baden-Württemberg and "a leading global horticulture company" that had worked with it since 2019, according to an EIT article of 25 August 2023, published while RoBoTec was in the EIC-EIT Digital Venture Acceleration Programme. The amount and the investors' names were not disclosed. RoBoTec's own press page names Ball Horticultural Company of Chicago as a strategic investor since 2019, and its press kit calls Ball its "first strategic customer". Ball has not announced the investment itself. The register shows matching capital increases, from €25,000 at incorporation to €41,070 in October 2022 and €45,450 in November 2023, per North Data.

The EIT article expected a full market launch in the second half of 2023. The formal launch came in July 2024, when Hortidaily and Tech.eu reported RoBoCut as officially available. Tech.eu said RoBoTec was developing a subscription model for software updates, support and data analytics, and was working on Phalaenopsis orchids. In March 2025 top agrar reported that the first systems were being adapted to customers, that a basic and a fully equipped version cost €500,000 to €750,000, and that the team was working on the third version of the machine. RoBoTec was one of two finalists in the main category of the magazine's 2024 innovation prize.

Other public money came early. A German federal economy ministry grant of €171,300, of which about €85,000 went to the Frankfurt University of Applied Sciences, paid for an augmented-reality remote service concept for the machine from October 2020 to September 2022, according to the university's announcement on idw; North Data records RoBoTec's share as €86,843. The parent, Bock Bio Science, won the €10,000 Bremen Environmental Award for RoBoCut in October 2019, according to AIPH and Hortidaily, and RoBoTec won the €10,000 Bremen Start-up Prize in 2021, when it had 14 employees, per AIPH. CORDIS lists no other EU project for the company.

On intellectual property, the register shows a run of German patent publications from 2019 to 2025 covering the propagation device, the nutrient medium, semi-autonomous plant processing and the neural network that recognises plant structures. The company counts "9 patent families" and "65+ patents and applications" on its product page and "over 60 patents" in its press kit.

The EIC Fund Question

RoBoCut was a grant-only award, so no EIC equity was part of the deal. RoBoTec does not appear on any of the 17 pages of the official list of EIC Fund investee companies, checked in October 2026.

Why Europe Should Care

The project's case to the EU was about supply chains: bring plant propagation, outsourced to low-wage countries, back to Europe, and cut the transport and contamination risk of shipping cuttings around the world. That fits the Commission's Vision for Agriculture and Food of 19 February 2025, which calls for a new approach to research and innovation, an EU digital strategy for agriculture and fewer critical import dependencies. Young plants are a small but basic link in that chain, and a European-built machine that makes them locally is the kind of capability the Vision describes.

The Verdict

RoBoTec has not been asked for comment for this article. It is based entirely on public records, company statements and EU project data, linked throughout.